Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (Q6)Mar 31, 2025 | (FY)Sep 30, 2024 | (Q6)Mar 31, 2024 | (FY)Sep 30, 2023 | (Q6)Mar 31, 2023 | (FY)Sep 30, 2022 | (Q6)Mar 31, 2022 | (FY)Sep 30, 2021 | (Q6)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 3.82%173.79M | 3.09%85.93M | -7.01%167.4M | 6.77%83.36M | 10.07%180.02M | -5.67%78.07M | 6.11%163.55M | 8.03%82.77M | 10.09%154.14M | 5.97%76.61M |
| Operating income | 3.82%173.79M | 3.09%85.93M | -7.01%167.4M | 6.77%83.36M | 10.07%180.02M | -5.67%78.07M | 6.11%163.55M | 8.03%82.77M | 10.09%154.14M | 5.97%76.61M |
| Other costs | -9.00%-63.45M | 5.51%-29.85M | 10.16%-58.21M | -40.10%-31.59M | -3.91%-64.79M | 21.61%-22.55M | 5.17%-62.36M | -6.25%-28.77M | -43.17%-65.76M | -22.90%-27.08M |
| Operating expenses | -9.00%-63.45M | 5.51%-29.85M | 10.16%-58.21M | -40.10%-31.59M | -3.91%-64.79M | 21.61%-22.55M | 5.17%-62.36M | -6.25%-28.77M | -43.17%-65.76M | -22.90%-27.08M |
| Gross profit | 1.05%110.34M | 8.33%56.07M | -5.24%109.19M | -6.77%51.76M | 13.87%115.23M | 2.81%55.52M | 14.49%101.2M | 9.01%54M | -6.06%88.38M | -1.45%49.54M |
| Employee expense | 0.25%-31.55M | 1.30%-16.15M | -0.97%-31.63M | 1.75%-16.36M | -0.70%-31.33M | -11.24%-16.65M | -11.08%-31.11M | -0.36%-14.97M | -5.77%-28.01M | -8.60%-14.92M |
| Revaluation surplus | 59.37%-259.01M | 36.81%-147.86M | -184.80%-637.44M | -2,750.38%-233.99M | -558.94%-223.82M | 64.82%-8.21M | -133.13%-33.97M | -2,574.44%-23.33M | 181.62%102.53M | 101.18%943K |
| -Changes in the fair value of investment property | 57.92%-263.62M | 27.92%-167.95M | -191.46%-626.46M | -10,096.41%-232.99M | -690.97%-214.94M | 86.92%-2.29M | -128.54%-27.17M | -148.29%-17.47M | 183.51%95.23M | 90.63%-7.04M |
| -Changes in the fair value of financial assets | 142.06%4.62M | 2,109.00%20.09M | -23.63%-10.98M | 83.12%-1M | -30.74%-8.88M | -1.06%-5.92M | -192.96%-6.79M | -173.46%-5.86M | 163.06%7.31M | 255.31%7.98M |
| Special items of operating profit | -81.94%1.46M | -510.11%-2.84M | 301.27%8.08M | -140.65%-465K | -0.50%-4.01M | -79.07%1.14M | -139.61%-3.99M | 387.68%5.47M | -3.16%10.08M | -135.52%-1.9M |
| Operating profit | 67.60%-178.76M | 44.35%-110.77M | -283.38%-551.81M | -725.94%-199.05M | -548.04%-143.93M | 50.27%31.8M | -81.43%32.13M | -37.14%21.16M | 463.42%172.99M | 187.77%33.66M |
| Financing cost | 23.15%-17.18M | 15.20%-9.79M | -22.66%-22.36M | -46.50%-11.54M | -250.34%-18.23M | -509.91%-7.88M | -374.29%-5.2M | -142.86%-1.29M | 40.70%-1.1M | 53.17%-532K |
| Share of profit from joint venture company | -67.67%-9.76M | -82.74%-6.45M | -11.30%-5.82M | -18.58%-3.53M | -40.69%-5.23M | -58.80%-2.98M | 80.47%-3.72M | 89.91%-1.87M | -4,743.77%-19.04M | -23,613.92%-18.58M |
| Special items of earning before tax | 74.48%-1.75M | ---- | -17.10%-6.87M | ---- | -224.31%-5.87M | ---- | 65.31%-1.81M | ---- | ---5.22M | ---- |
| Earning before tax | 64.65%-207.46M | 40.69%-127.01M | -238.71%-586.86M | -1,122.33%-214.13M | -909.86%-173.26M | 16.39%20.95M | -85.51%21.39M | 23.64%18M | 396.20%147.64M | 136.93%14.56M |
| Tax | 19.93%-8.21M | 8.30%-3.96M | -20.99%-10.25M | -4.77%-4.32M | -5.94%-8.48M | 32.28%-4.13M | 24.32%-8M | 24.00%-6.09M | -8.38%-10.57M | -26.55%-8.02M |
| After-tax profit from continuing operations | 63.88%-215.67M | 40.04%-130.97M | -228.56%-597.11M | -1,398.83%-218.45M | -1,456.85%-181.74M | 41.30%16.82M | -90.23%13.39M | 82.06%11.9M | 329.99%137.07M | 114.29%6.54M |
| Earning after tax | 63.88%-215.67M | 40.04%-130.97M | -228.56%-597.11M | -1,398.83%-218.45M | -1,456.85%-181.74M | 41.30%16.82M | -90.23%13.39M | 82.06%11.9M | 329.99%137.07M | 114.29%6.54M |
| Minority profit | 110.00%1K | 116.67%1K | -120.41%-10K | 98.74%-6K | 103.50%49K | 35.19%-477K | -2,759.18%-1.4M | -7,260.00%-736K | 23.44%-49K | 84.38%-10K |
| Profit attributable to shareholders | 63.88%-215.67M | 40.04%-130.97M | -228.47%-597.1M | -1,362.97%-218.44M | -1,328.69%-181.79M | 36.85%17.3M | -89.21%14.8M | 93.02%12.64M | 330.32%137.12M | 114.33%6.55M |
| Basic earnings per share | 63.84%-1.96 | 39.90%-1.19 | -228.48%-5.42 | -1,337.50%-1.98 | -1,369.23%-1.65 | 45.45%0.16 | -89.52%0.13 | 83.33%0.11 | 329.63%1.24 | 114.63%0.06 |
| Diluted earnings per share | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.